Why China Medical Systems FY2025 Profits Dropped Despite Growth
This episode explores the strategic evolution of a pharmaceutical group as it transitions into an innovation-focused global player. By revitalising growth drivers through a refined research model, China Medical System is successfully navigating industry shifts and optimizing its product portfolio. We delve into how a commitment to unmet medical needs and a robust international footprint are paving the way for a sustainable growth trajectory. • Breakthrough therapies reaching the market and the diverse pipeline of innovative drugs currently under regulatory review • How a hub-based…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.